The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

Nasal polyps are soft, noncancerous growths on the lining of the nose or sinuses. These growths, while painless, can cause blockages that prevent the sinuses from draining properly. This can make it ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...

Local immunoglobulin levels were found to be significantly higher in polyp tissue specimens, but not in the blood, of patients with nasal polyps. Nasal polyp development may be associated with ...

Circulating B cell–activating factor was shown to be a potential biomarker in identifying blood eosinophil counts and risk of postoperative nasal polyp recurrence among patients with chronic ...

Nasal cancer is rare, but it can be aggressive. Early diagnosis and treatment can often help keep it from spreading. Share on Pinterest Getty Images/FG Trade Nasal cancer, also known as nasal cavity ...

Please provide your email address to receive an email when new articles are posted on . Wenyi Chen, of the department of otolaryngology-head and neck surgery at Third Affiliated Hospital of Sun ...

Please provide your email address to receive an email when new articles are posted on . A combined set of clinical and biological variables predicted polyp recurrence and severity among patients who ...

The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...

Not only adults, nasal polyps can also occur in children. Polyps are an inflammation of the nasal membranes and sinuses that lasts more than 12 weeks. This condition is actually a soft, painless, ...

– Xolair is the first biologic for the treatment of nasal polyps that targets and blocks immunoglobulin E (IgE), a key driver of inflammation – – Xolair is now FDA-approved across three diseases and ...